Territory: Texas Medical Center, Houston, Katy, Beaumont, Baytown, Kingwood, Humble, Cleveland, Lufkin, Woodlands, Conroe, Huntsville, College Station, and Cypress
Product Portfolio: Rheumatology, Dermatology, Neurology, Gastroenterology, Oncology, HIV, Hep C
Launched brand awareness and sales in the Rheumatoid Arthritis, Ankylosing Spondylitis, Osteoporosis, Psoriatic Arthritis, Lupus, Gout, Plaque Psoriasis, Multiple Sclerosis and Atopic dermatitis therapeutic markets
Accomplishments
Achieves over a 100% monthly goal in patient prescription referrals with a territory valuation over $10 million
Comprehensive disease state management and case management for patients with auto-immune disease states that require specialty pharmacy biologic therapies
Coordination or care with Pharmacists, Clinical care RN’s, Infusion management centers, and Home Health Teams
Management of reimbursement support i.e.; medical benefits coverage, prior authorization approval, patient assistance programs, prescription status communication, therapy monitoring, IT platform, and patient education services
Revenue cycle management to include: 340 B programs, insurance eligibility, charge capture, claims coding, claims submission, claims clearing house, back-end procedural follow up, and rectifying claim submissions and denials
Specialty Account Representative
ANTARES PHARMACEUTICALS
Ewing, NJ
12.2013 - 12.2017
Rheumatology & Dermatology
Territory Multi-State: South Central Texas and Louisiana: Texas Medical Center, Houston, Clear Lake, Galveston, Beaumont, Baytown, Kingwood, Humble, Cleveland, Lufkin, Woodlands, Conroe, Huntsville, Victoria, Corpus Christi, Austin, and San Antonio - Lake Charles, Alexandria, and Lafayette
Product Portfolio: Advance prostate cancer with oral Erleada (apalutamide) for Metastatic castration-sensitive prostate cancer (mCSPC) and non-Metastatic castration-resistant prostate cancer (nmCRPC)
Advanced bladder cancer with oral Balversa (erdafitnib) for Metastatic urothelial carcinoma targeting FGFR3 or 2 mutations; with targeted treatment of Balversa based on FDA-companion diagnostic testing for FGFR3 or 2 mutations
Instituions: MD Anderson, Houston Methodist Hospitals, Dan L Duncan Comprehensive Cancer Center at Baylor St
Luke Medical Center, Memorial Herman Hospitals, HCA Healthcare Hospitals, Baptist Cancer Center, Texas Oncology, Millennium Oncology, Oncology Consultants, Houston Metro Urology, Northwood’s Urology, etc.
Accomplishments
S Circle Award winner
2021 President’s Circle Award winner
Current 200% to goal on Balversa
Balversa Texas district training lead
Strong knowledge on assigned oncology products and their related markets in all areas relevant to internal and external customers: such as, community oncologists, advanced practice registered nurses, mid-level providers, and pharmacists
Conducts successful partnerships with OCE, KAM, UBAM, FRAS/UFRAS, and other Janssen team members and counterparts to share ideas and information to enhance business results
Utilization of speaker budgets, lunches, conferences, meetings, ZERO prostate walks to provide clinical knowledge to prospective customers; while enhancing and reinforcing long-lasting relationships with customers
2015, Presidents Club Award Winner (Top 5% of Sales in Nation)
2015, ranked 5/40 in the nation
2014, ranked 8/40 in the nation
Experienced in Injectable/ Buy and Bill reimbursement environments
Key Account Management Expertise with Infusion Centers, Hospital/Outpatient Care, IDN’s, GPO’s, VA-DOD, Specialty Pharmacy, Medicare Part B, and State Medicaid selling strategies
Conducted Regional Field Coaching, Leadership Development, and On-Boarding for new hires
Secured the addition of Otrexup to The Texas Children’s Hospital Formulary
Exceptional Management of Diverse Business Portfolio’s and Maintained Collaborative Experience with National Account Managers, Product Brand Managers, Thought Leaders, and Sales Professionals throughout the Region.
Medical Information Scientist Lead
01.2003
Lead
01.2002
Managed Care, for Nexium
2001, Sales Value Proposition Award Winner
Achieved over 100% in district and national targeted metrics
Launched Nexium above projected forecasts, in a territory that was dominated by a strong competitive product and limited physician access
Organized and developed CME programs, for the Best of DDW (Digestive Disease Week)
Participated in the Gastroenterological Society, Cardiovascular Society, and Managed Care Health Fairs
Education
Bachelor of Science - Political Science
Sam Houston State University
Accomplishments
United States Army Reserve
Honorable Discharge
Affiliations
Alpha Kappa Alpha Sorority, Inc. American Heart Association Jack n Jill of America, Inc. March of Dimes
Resume
Additional Information
Accomplishments
, 2013, ranked 10/32 in region
2012,National Founder’s President’s Club Award Winner (Top 3% of Sales in Nation)
Timeline
Oncology Sales Specialist, President
JOHNSON & JOHNSON COMPANIES
01.2022
PHARMACEUTICAL SALES
JANSSEN PHARMACEUTICLS, IQVIA
05.2021 - Current
Specialty Pharmacy Account Executive
SOUTHSIDE SPECIALTY PHARMACY
06.2018 - 05.2021
National Field Advisory Board Member
01.2017
Regional Sales, Regional Leader
01.2016
STAR Conference Lead Coordinator
01.2015 - 01.2016
Specialty Account Representative
ANTARES PHARMACEUTICALS
12.2013 - 12.2017
Senior Specialty Sales Representative
IMPAX LABORATORIES, Texas Medical Center
06.2006 - 12.2013
Professional Sales Representative
MCNEIL NEUROLOGICS, INC, JOHNSON & JOHNSON COMPANIES